ITeos Therapeutics | ARS: Annual Report to Security Holders
ITeos Therapeutics | DEFA14A: Others
ITeos Therapeutics | DEF 14A: Definitive information statements
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gall Matthew
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Call Matthew
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer McGrath Yvonne
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Detheux Michel
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DeSimone Jill
ITeos Therapeutics | 3: Initial statement of beneficial ownership of securities-Director DeSimone Jill
ITeos Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
ITeos Therapeutics | 10-K: Annual report
ITeos Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-EcoR1 Capital, LLC(5.4%),Oleg Nodelman(5.4%), etc.
ITeos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(3.5%),BVF Inc.(3.5%), etc.
ITeos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.17%)
ITeos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(11.9%)
ITeos Therapeutics | 8-K: Current report
ITeos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Millennium Management LLC(2.7%),Millennium Group Management LLC(2.7%), etc.
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer McGrath Yvonne
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Operating Officer Call Matthew
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Gall Matthew
No Data